IL132094A0 - Methods and compositions for treatment of ovarian cancer - Google Patents

Methods and compositions for treatment of ovarian cancer

Info

Publication number
IL132094A0
IL132094A0 IL13209498A IL13209498A IL132094A0 IL 132094 A0 IL132094 A0 IL 132094A0 IL 13209498 A IL13209498 A IL 13209498A IL 13209498 A IL13209498 A IL 13209498A IL 132094 A0 IL132094 A0 IL 132094A0
Authority
IL
Israel
Prior art keywords
compositions
treatment
methods
ovarian cancer
ovarian
Prior art date
Application number
IL13209498A
Other languages
English (en)
Original Assignee
Baker Norton Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baker Norton Pharma filed Critical Baker Norton Pharma
Publication of IL132094A0 publication Critical patent/IL132094A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
IL13209498A 1997-03-27 1998-03-27 Methods and compositions for treatment of ovarian cancer IL132094A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4162897P 1997-03-27 1997-03-27
PCT/US1998/006232 WO1998042330A1 (en) 1997-03-27 1998-03-27 Methods and compositions for treatment of ovarian cancer

Publications (1)

Publication Number Publication Date
IL132094A0 true IL132094A0 (en) 2001-03-19

Family

ID=21917518

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13209498A IL132094A0 (en) 1997-03-27 1998-03-27 Methods and compositions for treatment of ovarian cancer

Country Status (11)

Country Link
US (1) US6334445B1 (xx)
EP (1) EP1007029A4 (xx)
JP (1) JP2001524963A (xx)
KR (1) KR20010005740A (xx)
CN (1) CN1254279A (xx)
AU (1) AU744095B2 (xx)
CA (1) CA2285391A1 (xx)
IL (1) IL132094A0 (xx)
NO (1) NO994631L (xx)
PL (1) PL335891A1 (xx)
WO (1) WO1998042330A1 (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2326485C (en) * 1998-04-01 2008-12-09 Rtp Pharma Inc. Anticancer compositions
WO1999065531A1 (en) 1998-06-18 1999-12-23 Johns Hopkins University School Of Medicine Polymers for delivery of nucleic acids
US6350464B1 (en) 1999-01-11 2002-02-26 Guilford Pharmaceuticals, Inc. Methods for treating ovarian cancer, poly (phosphoester) compositions, and biodegradable articles for same
US6537585B1 (en) 1999-03-26 2003-03-25 Guilford Pharmaceuticals, Inc. Methods and compositions for treating solid tumors
DE10244847A1 (de) * 2002-09-20 2004-04-01 Ulrich Prof. Dr. Speck Medizinische Vorrichtung zur Arzneimittelabgabe
JP2006514698A (ja) * 2002-10-30 2006-05-11 スフェリックス， インコーポレイテッド ナノ粒子生物活性物質
WO2007035842A2 (en) * 2005-09-21 2007-03-29 Ccc Diagnostics, Llc Comprehensive diagnostic testing procedures for personalized anticancer chemotherapy (pac)
JP5579057B2 (ja) * 2007-06-01 2014-08-27 アブラクシス バイオサイエンス， エルエルシー 再発性癌の処置のための方法および組成物
WO2011139899A2 (en) 2010-05-03 2011-11-10 Teikoku Pharma Usa, Inc. Non-aqueous taxane pro-emulsion formulations and methods of making and using the same
JO3685B1 (ar) 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
CN103432141A (zh) * 2013-08-29 2013-12-11 南京大学 Chukrasone A在治疗卵巢癌药物中的应用
WO2017066786A1 (en) * 2015-10-16 2017-04-20 Carefusion 303, Inc. Readmission risk scores

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5620875A (en) * 1995-02-17 1997-04-15 University Of Portland Transfer of taxol from yew tree cuttings into a culture medium over time

Also Published As

Publication number Publication date
EP1007029A1 (en) 2000-06-14
KR20010005740A (ko) 2001-01-15
WO1998042330A1 (en) 1998-10-01
PL335891A1 (en) 2000-05-22
CA2285391A1 (en) 1998-10-01
NO994631L (no) 1999-11-23
EP1007029A4 (en) 2003-03-26
AU744095B2 (en) 2002-02-14
JP2001524963A (ja) 2001-12-04
AU6787498A (en) 1998-10-20
CN1254279A (zh) 2000-05-24
NO994631D0 (no) 1999-09-23
US6334445B1 (en) 2002-01-01

Similar Documents

Publication Publication Date Title
HUP0104717A3 (en) Compositions and methods for therapy and diagnosis of ovarian cancer
IL189132A0 (en) Pharmaceutical compositions for the treatment of prostate hypertrophy and prostate cancer
AP9700939A0 (en) Compounds and methods for the treatment of cancer
AU2212299A (en) Compositions and methods for the treatment of tumor
EP0942742A4 (en) THERAPEUTIC COMPOSITIONS FOR CANCER TREATMENT
PL337531A1 (en) Compositions for and methods of inhibiting photo-ageing of skin
HK1040944A1 (en) Methods and compositions for the prevention and treatment of anemia
AU1980995A (en) Methods and compositions for treatment of breast cancer
ZA985028B (en) Method of treating liver tumours and pharmaceutical compositions for use therein
PL352931A1 (en) Compositions and uses of et743 for treating cancer
EP0758196A4 (en) COMPOSITIONS AND METHODS FOR TREATING TUMORS
IL136110A0 (en) Methods and compositions for the treatment of psoriasis
AU9016898A (en) Methods and compositions for treatment of restenosis
IL132094A0 (en) Methods and compositions for treatment of ovarian cancer
IL114119A0 (en) Compositions and methods for the treatment of tumors
IL124650A0 (en) Methods and therapeutic compositions for treating cancer
IL141426A0 (en) Compositions and methods for the treatment of tumor
IL143212A0 (en) Compositions and methods for the treatment of tumor
GB2309990B (en) Compositions and processes for treating hydrocarbon-bearing formations
EP1030681A4 (en) METHOD AND COMPOSITIONS FOR INHIBITING ANGIOGENESIS AND TREATING CANCER
GB9819999D0 (en) Treatment of cancer
GB9814269D0 (en) 9a-Aza-3-ketolides, compositions containing such compounds and methods of treatment
AU5097099A (en) Methods and compositions for cancer treatment
IL117277A0 (en) Methods of inhibiting ovarian cancer
EP0929540A4 (en) ANTI-TUMOR COMPOSITIONS AND THERAPEUTIC METHODS